STERIS Plc (Ireland) (STE)
211.18
+2.64
(+1.27%)
USD |
NYSE |
Oct 05, 16:00
211.18
0.00 (0.00%)
After-Hours: 20:00
STERIS Enterprise Value : 21.91B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 21.91B |
| October 01, 2026 | 21.99B |
| September 30, 2026 | 22.05B |
| September 29, 2026 | 22.12B |
| September 28, 2026 | 22.15B |
| September 25, 2026 | 21.95B |
| September 24, 2026 | 21.93B |
| September 23, 2026 | 22.05B |
| September 22, 2026 | 21.93B |
| September 21, 2026 | 21.76B |
| September 18, 2026 | 21.57B |
| September 17, 2026 | 21.86B |
| September 16, 2026 | 22.04B |
| September 15, 2026 | 22.08B |
| September 14, 2026 | 22.41B |
| September 11, 2026 | 22.13B |
| September 10, 2026 | 22.29B |
| September 09, 2026 | 22.55B |
| September 08, 2026 | 22.87B |
| September 04, 2026 | 23.47B |
| September 03, 2026 | 23.69B |
| September 02, 2026 | 24.04B |
| September 01, 2026 | 23.97B |
| August 31, 2026 | 24.26B |
| August 28, 2026 | 24.37B |
| Date | Value |
|---|---|
| August 27, 2026 | 24.29B |
| August 26, 2026 | 24.66B |
| August 25, 2026 | 24.63B |
| August 24, 2026 | 24.77B |
| August 21, 2026 | 24.77B |
| August 20, 2026 | 24.56B |
| August 19, 2026 | 24.68B |
| August 18, 2026 | 24.23B |
| August 17, 2026 | 23.98B |
| August 14, 2026 | 24.32B |
| August 13, 2026 | 24.59B |
| August 12, 2026 | 24.65B |
| August 11, 2026 | 24.80B |
| August 10, 2026 | 24.87B |
| August 07, 2026 | 24.73B |
| August 06, 2026 | 24.18B |
| August 05, 2026 | 24.27B |
| August 04, 2026 | 24.28B |
| August 03, 2026 | 24.26B |
| July 31, 2026 | 23.85B |
| July 30, 2026 | 24.12B |
| July 29, 2026 | 24.47B |
| July 28, 2026 | 24.03B |
| July 27, 2026 | 22.87B |
| July 24, 2026 | 22.45B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medtronic Plc | 130.52B |
| Trinity Biotech Plc | 136.51M |
| ResMed, Inc. | 30.93B |
| Alkermes Plc | 7.911B |
| Amarin Corp. Plc | -50.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 201.00M |
| Revenue (Quarterly) | 1.493B |
| Total Expenses (Quarterly) | 1.293B |
| EPS Diluted (Quarterly) | 2.044 |
| Gross Profit Margin (Quarterly) | 45.84% |
| Profit Margin (Quarterly) | 13.47% |
| Earnings Yield | 3.87% |
| Operating Earnings Yield | 5.70% |
| Normalized Earnings Yield | 4.017 |